Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Cost of Revenue (2017 - 2025)

Historic Cost of Revenue for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $36.1 million.

  • Inspire Medical Systems' Cost of Revenue rose 23.06% to $36.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $133.2 million, marking a year-over-year increase of 832.53%. This contributed to the annual value of $133.2 million for FY2025, which is 832.53% up from last year.
  • Inspire Medical Systems' Cost of Revenue amounted to $36.1 million in Q4 2025, which was up 23.06% from $31.8 million recorded in Q3 2025.
  • Over the past 5 years, Inspire Medical Systems' Cost of Revenue peaked at $36.1 million during Q4 2025, and registered a low of $6.0 million during Q1 2021.
  • For the 5-year period, Inspire Medical Systems' Cost of Revenue averaged around $22.6 million, with its median value being $24.3 million (2023).
  • In the last 5 years, Inspire Medical Systems' Cost of Revenue soared by 28474.92% in 2021 and then plummeted by 192.91% in 2025.
  • Over the past 5 years, Inspire Medical Systems' Cost of Revenue (Quarter) stood at $11.2 million in 2021, then soared by 98.57% to $22.2 million in 2022, then increased by 26.64% to $28.1 million in 2023, then increased by 28.28% to $36.0 million in 2024, then rose by 0.23% to $36.1 million in 2025.
  • Its Cost of Revenue stands at $36.1 million for Q4 2025, versus $31.8 million for Q3 2025 and $34.7 million for Q2 2025.